A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...
The fear over the spread of HMPV virus that led to concerns if it will trigger Covid-19-like health emergency. Is HMPV same ...
The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...
Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...
Former WHO chief scientist Soumya Swaminathan has reassured that the Human Metapneumovirus (HMPV) is not a cause for concern, ...
For years, we’ve exposed the federal government’s role — especially the Intelligence Community — in concealing the origins of ...
Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.
While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...
It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...
A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...
COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised ...
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...